Glyoxalase 1 and protein kinase Cλ as potential therapeutic targets for late‑stage breast cancer

Author:

Motomura Hitomi1,Ozaki Ayaka1,Tamori Shoma1,Onaga Chotaro1,Nozaki Yuka1,Waki Yuko1,Takasawa Ryoko2,Yoshizawa Kazumi2,Mano Yasunari2,Sato Tsugumichi2,Sasaki Kazunori3,Ishiguro Hitoshi4,Miyagi Yohei5,Nagashima Yoji6,Yamamoto Kouji7,Sato Keiko8,Hanawa Takehisa2,Tanuma Sei-Ichi1,Ohno Shigeo3,Akimoto Kazunori1

Affiliation:

1. Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278‑8510, Japan

2. Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278‑8510, Japan

3. Department of Molecular Biology, Yokohama City University, School of Medicine, Kanagawa 236‑0004, Japan

4. Department of Urology, Yokohama City University Graduate School of Medicine, Kanagawa 236‑0004, Japan

5. Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Kanagawa 241‑8515, Japan

6. Department of Surgical Pathology, Tokyo Women's Medical University Hospital, Tokyo 162‑8666, Japan

7. Department of Biostatistics, Yokohama City University, School of Medicine, Kanagawa 236‑0004, Japan

8. Department of Information Sciences, Faculty of Science and Technology, Tokyo University of Science, Chiba 278‑8510, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3